Rein Therapeutics Inc.
RNTX
$1.27
$0.1412.39%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.72M | 7.43M | 12.87M | 17.65M | 21.92M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | 252.00K | 1.22M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 880.00K | 903.00K | 792.00K | 780.00K | 25.00K |
Total Current Assets | 6.60M | 8.33M | 13.66M | 18.68M | 23.16M |
|
|||||
Total Current Assets | 6.60M | 8.33M | 13.66M | 18.68M | 23.16M |
Net Property, Plant & Equipment | 1.00K | 1.00K | 1.00K | 1.00K | 2.00K |
Long-term Investments | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M |
Goodwill | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M |
Total Other Intangibles | 42.20M | 42.20M | 42.20M | 79.20M | 79.20M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.35M | 766.00K | 2.00K | 2.00K | 709.00K |
Total Assets | 57.48M | 57.63M | 62.19M | 104.22M | 109.40M |
|
|||||
Total Accounts Payable | 6.03M | 1.15M | 911.00K | 1.08M | 782.00K |
Total Accrued Expenses | 1.48M | 4.66M | 4.72M | 4.51M | 3.90M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 183.00K | 164.00K | 122.00K | 73.00K | 255.00K |
Total Other Current Liabilities | 183.00K | 164.00K | 122.00K | 73.00K | 255.00K |
Total Current Liabilities | 7.69M | 5.98M | 5.75M | 5.66M | 4.94M |
|
|||||
Total Current Liabilities | 7.69M | 5.98M | 5.75M | 5.66M | 4.94M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.77M | 1.77M | 2.05M | 3.33M | 3.44M |
Total Liabilities | 9.47M | 7.75M | 7.80M | 8.99M | 8.38M |
|
|||||
Common Stock & APIC | 366.75M | 361.81M | 360.81M | 360.67M | 360.61M |
Retained Earnings | -363.72M | -356.90M | -351.40M | -310.42M | -304.57M |
Treasury Stock & Other | -22.00K | -32.00K | -18.00K | -26.00K | -22.00K |
Total Common Equity | 3.01M | 4.87M | 9.39M | 50.23M | 56.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 45.01M | 45.01M | 45.01M | 45.01M | 45.01M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 45.01M | 45.01M | 45.01M | 45.01M | 45.01M |
|
|||||
Total Common Equity | 3.01M | 4.87M | 9.39M | 50.23M | 56.02M |
Total Preferred Equity | 45.01M | 45.01M | 45.01M | 45.01M | 45.01M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 48.01M | 49.88M | 54.39M | 95.23M | 101.02M |
|